Stock Ratings | Wells Fargo raised its price target for Google (GOOGL) to $438; HC Wainwright raised its price target for Greenwich LifeSciences (GLSI) to $69, representing a potential upside of 370.99%.
Greenwich LifeSciences, Inc. GLSI | 0.00 | |
Taysha Gene Therapies, Inc. TSHA | 0.00 | |
AMC Entertainment Holdings, Inc. Class A AMC | 0.00 | |
Eledon Pharmaceuticals, Inc. ELDN | 0.00 | |
USA Rare Earth USAR | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
HC Wainwright & Co.: Maintaining a "buy" rating on Greenwich LifeSciences ( Greenwich LifeSciences, Inc.(GLSI.US) ), while raising the price target from $50 to $69.
Goldman Sachs: Maintaining a "buy" rating on Taysha Gene Therapies ( Taysha Gene Therapies, Inc.(TSHA.US) ), while raising its price target from $11 to $13.
Wedbush: Maintaining its "Outperform Market" rating for AMC Entertainment ( AMC Entertainment Holdings, Inc. Class A(AMC.US) ), while raising its price target from $3 to $4.
Rodman & Renshaw: An initial rating of "buy" for Eledon Pharmaceuticals ( Eledon Pharmaceuticals, Inc.(ELDN.US) ), with a target price of $12.
Roth Capital: Maintaining a "buy" rating on USA Rare Earth ( USA Rare Earth(USAR.US) ), while lowering the price target from $40 to $30.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| Greenwich LifeSciences, Inc.(GLSI.US) | to lift | $69.0 | $14.65 | 370.99% | HC Wainwright & Co. |
| Taysha Gene Therapies, Inc.(TSHA.US) | to lift | $13.0 | $5.67 | 129.28% | Goldman Sachs |
| AMC Entertainment Holdings, Inc. Class A(AMC.US) | to lift | $4.0 | $2.2 | 81.82% | Wedbush |
| Relay Therapeutics, Inc.(RLAY.US) | to lift | $31.0 | $19.3 | 60.62% | Goldman Sachs |
| Meta Platforms(META.US) | to lift | $1000.0 | $643.81 | 55.33% | Rothschild & Co |
| Eledon Pharmaceuticals, Inc.(ELDN.US) | Initial classification | $12.0 | $3.95 | 203.8% | Rodman & Renshaw |
| USA Rare Earth(USAR.US) | cut | $30.0 | $15.8 | 89.87% | Roth Capital |
| CoreWeave(CRWV.US) | cut | $150.0 | $79.58 | 88.49% | Jefferies |
| Airo Group Holdings, Inc.(AIRO.US) | cut | $13.0 | $7.08 | 83.62% | Mizuho |
| Phoenix Education Partners, Inc.(PXED.US) | cut | $51.0 | $30.08 | 69.55% | B. Riley Securities |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Benchmark: Maintaining a "buy" rating on AMC Entertainment ( AMC Entertainment Holdings, Inc. Class A(AMC.US) ) stock, while raising the price target from $2.50 to $3.00.
Wells Fargo: Maintaining an "overweight" rating on Amazon ( Amazon.com, Inc.(AMZN.US) ), while raising its price target from $313 to $322.
Susquehanna: Maintaining a "positive" rating on Credo Technology Group Credo Technology(CRDO.US) , with a price target raised from $235 to $250.
Evercore ISI Group: Maintaining its "Outperform Market" rating for Datadog ( Datadog(DDOG.US) ), while raising its price target from $265 to $280.
Wells Fargo: Maintaining an "overweight" rating on Google-A ( Alphabet Inc. Class A(GOOGL.US) ) stock, while raising its price target from $416 to $438.
Needham: Maintaining a "buy" rating on Robinhood Markets ( Robinhood(HOOD.US) ), while raising the price target from $97 to $123.
Raymond James: Maintaining a "strong buy" rating for Meta Meta Platforms(META.US) ) stock, while raising the price target from $825 to $850.
Morgan Stanley: Maintaining an "overweight" rating on Palo Alto Networks Palo Alto Networks, Inc.(PANW.US) ) stock, while raising the price target from $320 to $387.
Rothschild & Co: Maintaining a "buy" rating on Meta Platforms Meta Platforms(META.US) ) stock, while raising the price target from $900 to $1000.
First Coverage
BMO Capital: Initial rating for Axsome Therapeutics ( Axsome Therapeutics, Inc.(AXSM.US) ) at "Outperform," with a price target of $310.
BMO Capital: MapLight Therapeutics ( MapLight Therapeutics, Inc.(MPLT.US) ) has an initial rating of "outperforming the market" with a price target of $46.
Benchmark: Stewart Information Services ( Stewart Information Services Corporation(STC.US) ) stock has a preliminary rating of "buy", with a target price of $87.
reduction
Barclays: Maintaining a "Market-Similar Weight" rating for CoreWeave ( CoreWeave(CRWV.US) ), while lowering its price target from $120 to $90.
BMO Capital: Maintaining its "Outperform Market" rating for Domino's Domino's Pizza, Inc.(DPZ.US) ), while lowering its price target from $450 to $420.
Barclays: Maintaining an "overweight" rating on IBM IBM Corp(IBM.US) ) stock, while lowering its price target from $350 to $288.
Mizuho: Maintaining a "neutral" rating on Whirlpool stock ( Whirlpool Corporation(WHR.US) ), while lowering the price target from $45 to $40.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.